Consumer Advocates Prefer DeLauro Antibiotics Bill Requiring 'Superior' Drugs To Draft 'Cures' Measure

Leading consumer advocacy groups are throwing their support behind a new legislative plan by Rep. Rosa DeLauro (D-CT) to spur development of antibiotics, saying the bill's mandate that drugs going through the pathway be superior to existing antibiotics makes it better than the draft House Cures bill's approach. DeLauro's bill, unveiled Thursday (Feb. 12), would let FDA approve certain antibacterial drugs for well-defined patient populations based on the results of clinical trials of human subjects, but unlike other bills would...